Squarepoint
HARP

Squarepoint’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Squarepoint’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,470
Closed -$116K – 3635
2021
Q3 		$116K Buy
+1,470
New +$148K ﹤0.01% 2637
2021
Q1 		– Sell
-1,731
Closed -$288K – 3769
2020
Q4 		$288K Hold
1,731
– – ﹤0.01% 2236
2020
Q3 		$294K Sell
1,731
-2,131
-55% -$307K ﹤0.01% 1810
2020
Q2 		$641K Sell
3,862
-2,901
-43% -$453K 0.01% 1166
2020
Q1 		$783K Buy
6,763
+3,431
+103% +$482K 0.02% 828
2019
Q4 		$493K Buy
+3,332
New +$505K ﹤0.01% 1786

Other funds holding HARP

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Squarepoint's HARP Position: Q4 2021 in Review

Squarepoint sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q4 2021, closing a stake of 1,470 shares — an estimated $116K sold.

Squarepoint first reported a position in HARP in Q4 2019 and held it in 6 quarters. The position peaked at $783K in Q1 2020. 84 funds tracked by Wall St. Rank hold HARP as of Q4 2021.

  • Squarepoint reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Squarepoint sold 1,470 Harpoon Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $116K.
  • Squarepoint first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q4 2019 and held it in 6 quarters.
  • Squarepoint's Harpoon Therapeutics, Inc. Common Stock position peaked at $783K in Q1 2020.
  • 84 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q4 2021.

Based on Squarepoint's 13F filing for Q4 2021, filed 14 Feb 2022.